I now have comprehensive information from the textbooks. Let me compile the full answers for both questions.
Question 2: Factors Affecting Enzyme Activity + Properties of Enzymes
Properties of Enzymes
Before diving into factors, here are the key properties of enzymes you need to know:
| Property | Explanation |
|---|
| Proteins | All enzymes are proteins (except ribozymes — RNA-based). |
| Catalysts | Speed up reactions without being consumed or permanently changed. |
| Specificity | Each enzyme acts on only one or a few specific substrates (binding specificity). |
| Reaction specificity | Catalyze only one type of reaction — no by-products. |
| Stereospecificity | Recognize only one enantiomeric (mirror image) form of a substrate (e.g., proteases act only on L-amino acids). |
| Do NOT shift equilibrium | They speed up reaching equilibrium but don't change the equilibrium constant (Keq). |
| Regulated | Activity is controlled by allosteric molecules, inhibitors, or covalent modification. |
— Henry's Clinical Diagnosis and Management by Laboratory Methods
Factors Affecting Enzyme Activity
1. Temperature
- Every 10°C rise in temperature approximately doubles enzyme activity (Q10 effect).
- However, high temperatures cause denaturation — enzymes lose their 3D shape and activity.
- Example: Creatine kinase (CK) denatures at 37°C; amylase at 45°C.
- Exception: Taq polymerase remains stable at 95°C (used in PCR).
- Low temperatures slow reactions but preserve enzyme stability — useful for storing samples.
2. pH
- Each enzyme has an optimal pH at which it works best.
- Pepsin (stomach): optimal pH ~2 (acidic)
- Trypsin (small intestine): optimal pH ~8 (slightly alkaline)
- Most body enzymes: optimal pH ~7.4
- pH affects the ionization of amino acids in the active site, changing enzyme shape and substrate binding. Extreme pH causes denaturation.
3. Substrate Concentration ([S])
- As [S] increases, reaction velocity (v) increases — more enzyme-substrate complexes form.
- At very high [S], the enzyme becomes saturated and velocity reaches a maximum (V
max).
- This relationship follows Michaelis-Menten kinetics: the Km (Michaelis constant) is the [S] at which velocity = ½ V
max. A lower Km means higher affinity for the substrate.
4. Enzyme Concentration
- If substrate is in excess, reaction rate is directly proportional to enzyme concentration — more enzyme molecules = more active sites = faster reaction.
5. Cofactors and Coenzymes
- Many enzymes require non-protein helpers:
- Cofactors: inorganic ions (Mg²⁺, Zn²⁺, Fe²⁺)
- Coenzymes: organic molecules (NAD⁺, FAD, Coenzyme A — most derived from vitamins)
6. Inhibitors (see Question 3 below)
Question 3: Enzyme Inhibition — Definition and Types
Definition
Any substance that decreases the velocity of an enzyme-catalyzed reaction is called an inhibitor.
Types of Enzyme Inhibition
A. Irreversible Inhibition
- Inhibitor binds to the enzyme via a covalent bond — permanent, cannot be reversed by dilution.
- Destroys enzyme function permanently.
- Example: Lead (Pb²⁺) irreversibly inhibits ferrochelatase (an enzyme in heme synthesis) by forming covalent bonds with cysteine's –SH group.
- Aspirin irreversibly inhibits cyclooxygenase (COX), blocking prostaglandin synthesis.
B. Reversible Inhibition
Inhibitor binds via non-covalent bonds — can be removed by dilution. Two main types:
1. Competitive Inhibition
- The inhibitor looks like the substrate and competes for the same active site.
- Substrate and inhibitor cannot bind simultaneously.
| Parameter | Effect |
|---|
Vmax | Unchanged — can be overcome by adding excess substrate |
| Km | Increased (apparent) — more substrate needed to reach ½ Vmax |
Lineweaver-Burk plot: Lines intersect on the y-axis (same 1/Vmax, different x-intercepts).
Pharma example: Statins (e.g., pravastatin, atorvastatin) competitively inhibit HMG-CoA reductase, blocking cholesterol synthesis. Methotrexate competitively inhibits dihydrofolate reductase (DHFR).
2. Noncompetitive Inhibition
- The inhibitor binds to a different site (allosteric site) — not the active site.
- Can bind to free enzyme OR the enzyme-substrate (ES) complex.
- Substrate binding is unaffected, but the reaction cannot proceed normally.
| Parameter | Effect |
|---|
Vmax | Decreased — cannot be overcome by adding more substrate |
| Km | Unchanged — substrate affinity is unaffected |
Lineweaver-Burk plot: Lines intersect on the x-axis (same –1/Km, different y-intercepts).
Example: Heavy metals like Hg²⁺ acting on –SH groups away from the active site.
3. Uncompetitive Inhibition
- Inhibitor binds only to the ES complex (not free enzyme).
- Both V
max and Km are decreased proportionally.
- Lineweaver-Burk plot: Parallel lines (same slope, different intercepts).
Quick Comparison Table
| Feature | Competitive | Noncompetitive | Uncompetitive |
|---|
| Binding site | Active site | Allosteric site | ES complex only |
Vmax | Unchanged | Decreased | Decreased |
| Km | Increased | Unchanged | Decreased |
| Reversible by excess [S]? | Yes | No | No |
| Lineweaver-Burk | Same y-intercept | Same x-intercept | Parallel lines |
Drug Examples (Important for Pharm D)
| Drug | Mechanism |
|---|
| Statins (atorvastatin) | Competitive inhibition of HMG-CoA reductase |
| Penicillin / Amoxicillin | Irreversible inhibition of bacterial cell wall synthesis enzymes |
| ACE inhibitors (captopril, enalapril) | Inhibit angiotensin-converting enzyme → vasodilation |
| Aspirin | Irreversible inhibition of COX (cyclooxygenase) |
| Methotrexate | Competitive inhibition of DHFR |
Sources: Lippincott's Illustrated Reviews Biochemistry 8th ed.; Henry's Clinical Diagnosis and Management by Laboratory Methods